The European & Developing Countries Clinical Trials Partnership (EDCTP) aims to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related and neglected infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.

Calls for Proposals

EDCTP opened new calls for research proposals under itsĀ second programme: diagnostic tools for poverty-related diseases; maximising the impact of EDCTP research; strategic projects with major cofunding; improved treatment; and clinical management of poverty-related diseases.

Read more

About us

EDCTP is a partnership between Europa and sub-Saharan Africa, a partnership between 14 African andĀ 14 European countries that jointly contribute to the fight against HIV/Aids, tuberculosis, malaria and other neglected infectious diseases.

Find out more about who we are!

Read more

Scope

EDCTP2 aims to contribute to the reduction of the social and economic burden of poverty-related diseases (PRDs) in developing countries, in particular in sub-Saharan Africa, by accelerating the clinical development of effective, safe, accessible, suitable and affordable medical interventions for PRDs in partnership with sub-Saharan Africa.

Read more

Latest news

25 April 2016

World Malaria Day 2016: joining forces to end malaria

There has been remarkable progress made in malaria control based on current World health Organisation estimates. Nonetheless, there is still…

Read more
20 April 2016

Abstract submission for the Eighth EDCTP Forum is now open

EDCTP is pleased to announce that as of today the service for submission of abstracts for the Eighth Forum is…

Read more